A R Thompson1, F Drenos, H Hafez, S E Humphries. 1. Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free & University College London Medical School, 5 University Street, London WC1E 6JF, UK.
Abstract
BACKGROUND: Candidate gene analysis has been frequently used in attempts to understand the pathological processes involved in many aspects of AAA disease. METHODS: This paper sets out a systems approach to reviewing AAA candidate gene analysis studies, whilst, explaining the key principles and design limitations of this universally applied technique. In addition we have performed a meta-analysis of six gene polymorphisms (ACE I/D, MTHFR+677C>T, MMP9-1562C>T, Il-1Beta/3953C>T, eNOS 4a/4b & TIMP1/+434C>T) reported in multiple case control studies. RESULTS AND CONCLUSIONS: Three of these polymorphisms were associated with a significant risk of AAA, ACE RR 1.33 [95% CI 1.20-1.48], MTHFR RR 1.14 [1.08-1.21] and MMP9 RR 1.09 [1.01-1.18]. These differences have been previously reported as equivocal, within a context of contradictory studies and as such this meta-analysis provides new evidence for their involvement in AAA disease. The plausibility of these findings is discussed within the context of a systems approach to the pathology of AAA disease.
BACKGROUND: Candidate gene analysis has been frequently used in attempts to understand the pathological processes involved in many aspects of AAA disease. METHODS: This paper sets out a systems approach to reviewing AAA candidate gene analysis studies, whilst, explaining the key principles and design limitations of this universally applied technique. In addition we have performed a meta-analysis of six gene polymorphisms (ACE I/D, MTHFR+677C>T, MMP9-1562C>T, Il-1Beta/3953C>T, eNOS 4a/4b & TIMP1/+434C>T) reported in multiple case control studies. RESULTS AND CONCLUSIONS: Three of these polymorphisms were associated with a significant risk of AAA, ACE RR 1.33 [95% CI 1.20-1.48], MTHFR RR 1.14 [1.08-1.21] and MMP9 RR 1.09 [1.01-1.18]. These differences have been previously reported as equivocal, within a context of contradictory studies and as such this meta-analysis provides new evidence for their involvement in AAA disease. The plausibility of these findings is discussed within the context of a systems approach to the pathology of AAA disease.
Authors: Georgios A Pitoulias; Konstantinos P Donas; Grigoris Chatzimavroudis; Giovanni Torsello; Dimitrios K Papadimitriou Journal: World J Surg Date: 2012-08 Impact factor: 3.352
Authors: L Smallwood; R Allcock; F van Bockxmeer; N Warrington; L J Palmer; B Iacopetta; J Golledge; P E Norman Journal: Br J Surg Date: 2008-10 Impact factor: 6.939
Authors: Gregory T Jones; Andrew R Thompson; Frank M van Bockxmeer; Hany Hafez; Jackie A Cooper; Jonathan Golledge; Stephen E Humphries; Paul E Norman; Andre M van Rij Journal: Arterioscler Thromb Vasc Biol Date: 2008-01-31 Impact factor: 8.311